My laboratory research focuses on the development of translational therapeutics for patients with multiple myeloma. My objective is to integrate concepts of myeloma biology, genomics and immunotherapy to improve patient outcomes by personalized therapeutic approaches. Currently, I am developing novel therapeutic approaches to benefit patients at high risk of poor outcomes, using both 2D and 3D models to study the interactions between myeloma cells and the tumor microenvironment.